Kodu・Aktsiate loetelu・GE HealthCare Technologies

GE HealthCare Technologies

Avatud

SektorTervishoid

73.66 -0.67

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

73.98

Max

75.09

Põhinäitajad
By Trading Economics
Sissetulek	163M 574M
Müük	164M 5.3B
P/E Sektori keskmine	16.988 57.371
Aktsiakasum	1.13
Dividenditootlus	0.19
Kasumimarginaal	10.84
Töötajad	54,000
EBITDA	198M 953M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+5.68% upside

Dividendid
By Acuity
Dividenditootlus Sektori keskmine	0.19% 2.23%
Järgmine tulemuste avaldamine	28. okt 2026
Järgmine dividendimakse kuupäev	13. nov 2026
Järgmine aktsia dividendi kuupäev (ex-date)	23. okt 2026

Turustatistika
By TradingEconomics
Turukapital	5.1B 33B
Eelmine avamishind	74.33
Eelmine sulgemishind	73.66

Uudiste sentiment

By Acuity

28%

72%

80 / 340 Pingereas Healthcare

GE HealthCare Technologies Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. aug 2026, 20:06 UTC

News

GE Healthcare Technologies appointed William Grogan as CFO, effective September 2026. BTIG reiterated its Buy rating with a $79 price target. Shares are higher since Tuesday's close.

18. aug 2026, 23:51 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, reaching above Tuesday's close despite elevated bond yields and ongoing inflation concerns.

17. aug 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading, reaching a notable increase while remaining above its 20-day moving average. No specific news was identified.

14. aug 2026, 19:46 UTC

GE Healthcare Technologies is trading roughly flat, with no specific news identified. Shares peaked earlier but have since settled back down.

13. aug 2026, 23:46 UTC

GE Healthcare Technologies shares declined in after-market trading, reflecting a slight drop since Thursday's close. The stock remained above its 20-day moving average.

12. aug 2026, 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

11. aug 2026, 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

10. aug 2026, 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

7. aug 2026, 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

6. aug 2026, 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

5. aug 2026, 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

4. aug 2026, 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3. aug 2026, 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31. juuli 2026, 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

30. juuli 2026, 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

29. juuli 2026, 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

28. juuli 2026, 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

27. juuli 2026, 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

24. juuli 2026, 20:03 UTC

Event

News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

23. juuli 2026, 23:41 UTC

Event

News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

22. juuli 2026, 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

21. juuli 2026, 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

20. juuli 2026, 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Võrdlus sarnastega

Hinnamuutus

GE HealthCare Technologies Prognoos

Hinnasiht

By TipRanks

5.68% tõus

12 kuu keskmine prognoos

Keskmine 79.07 USD 5.68%

Kõrge 92 USD

Madal 70 USD

Põhineb 14 Wall Streeti analüütiku instrumendi GE HealthCare Technologies 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

Osta

Hoia

Müü

Põhineb 14 analüütiku instrumendi GE HealthCare Technologies aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

80 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.